The inconsistent findings from different studies could be due to the different origins of AMLs, and AML cases with CD34+CD38−ALDHbr leukemia cells might be derived from more primitive cells, possibly translating to a poorer prognosis. This evidence concerns the gene CD34 and leukemia.